AF
AMED

Amalgamated Financial’s Amedisys AMED Stock Holding History

Amalgamated Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4.14M Buy
+24,055
New +$3.59M 0.03% 562

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Amalgamated Financial's AMED Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Amedisys (AMED) in Q1 2022: 24,055 shares worth $4.14M. The stake represents 0.03% of the portfolio and ranks #562 among its holdings.

329 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • Amalgamated Financial held 24,055 shares of Amedisys worth $4.14M as of Q1 2022.
  • Amedisys was a new Amalgamated Financial position in Q1 2022.
  • Amedisys made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #562 holding.
  • 329 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.